Professor Lyu Aiping is Dean and Chair Professor of the School of Chinese Medicine, HKBU. He is also Chief Researcher of the China Academy of Chinese Medical Sciences (CACMS). Admitted to Jiangxi University of Traditional Chinese Medicine at the age of 15, he was one of the youngest undergraduate students at the University. After earning his Bachelor’s degree in Chinese medicine, he went on to pursue research at the China Academy of Traditional Chinese Medicine (now CACMS) and obtained his Master’s degree and PhD there. In 2008, he won the National Science Fund for Distinguished Young Scholars from the National Natural Science Foundation of China. He served consecutively as Director of the Institute of Basic Theory of CACMS, Managing Director of the National Pharmaceutical Engineering Centre for Solid Preparations and Executive Deputy Director of the Institute of Basic Research in Clinical Medicine of CACMS. He joined HKBU in 2012 and was appointed the Dr. Kennedy Y.H. Wong Endowed Chair of Chinese Medicine in the same year.
Professor Lyu’s research interests span from the clinical evaluation with RCT (randomised controlled trial) focusing on RA (rheumatoid arthritis) with Chinese medicine diagnosis to the standardisation of Chinese medicine diagnosis and new drug discovery. In accordance with the proposal made by Professor Lyu, the University established in 2012 the Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases and appointed Professor Lyu as Founding Director of the Institute. In 2015, his team developed a novel aptamer-functionalised delivery system that achieves osteoblast-specific delivery of drug molecules to promote bone formation. This new system has advanced the development of targeted therapies for osteoporosis. In 2017, his team pursued a space life science study conducted on board China’s first cargo spacecraft, Tianzhou-1, to investigate the effect of the CKIP-1 gene on bone formation under microgravity conditions in space. HKBU is the only university outside the Chinese Mainland to be invited to conduct a scientific research project on Tianzhou-1.
A leading figure in the standardisation of Chinese medicine, Professor Lyu was appointed Deputy Director of the Chinese Medicine Standardization Office under the State Administration of Traditional Chinese Medicine in 2011 before taking the helm of the Office in 2013. He has not only built a team for the International Organization for Standardization (ISO) to manage and support work on international standards for Chinese medicine. He has also led a team of experts to formulate three sets of national as well as ISO standards for Chinese medicine. Professor Lyu has served as Head and Spokesperson of the China delegation to plenary meetings of the ISO/TC249 since 2009 and is President-designate of the Good Practice in Traditional Chinese Medicine Research Association, formed under the auspices of the European Union.
An eminent scholar in the standardisation of Chinese medicine, Professor Lyu has won numerous prestigious honours, including the Li Shizhen Innovation Award (2015), the Award for Outstanding Contribution to Standardisation in China (2014) and the Award for Promoting Standardisation (2014), testifying to his untiring efforts in and contribution to new drug discovery and standardisation of Chinese medicine. He has published over 30 books and 500 articles, of which more than 260 were published in Science Citation Index (SCI) journals such as Nature Medicine. He has obtained more than 60 patents from his research. He is a member of the 11th and 12th National Committee of the Chinese People’s Political Consultative Conference as well as the 11th Beijing Committee of the Chinese People’s Political Consultative Conference.
“I am delighted that HKBU has appointed Professor Lyu Aiping, an experienced and distinguished scholar, as the Dr. Kennedy Y.H. Wong Endowed Chair of Chinese Medicine. I wish that through its outstanding team and international platform, the School of Chinese Medicine will develop more quality drugs and therapies under the able leadership of Professor Lyu, thereby spreading them to the world for the benefit of humankind.”